PE20141607A1 - Compuestos heterociclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparacion - Google Patents
Compuestos heterociclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparacionInfo
- Publication number
- PE20141607A1 PE20141607A1 PE2014000641A PE2014000641A PE20141607A1 PE 20141607 A1 PE20141607 A1 PE 20141607A1 PE 2014000641 A PE2014000641 A PE 2014000641A PE 2014000641 A PE2014000641 A PE 2014000641A PE 20141607 A1 PE20141607 A1 PE 20141607A1
- Authority
- PE
- Peru
- Prior art keywords
- compounds
- drugs
- contain
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A COMPUESTOS DE FORMULA (I), EN DONDE: A ES UN ENLACE, -CH2-, -CH2CH2-, -CH2CH2CH2-, ENTRE OTROS; B ES -CH2-, ENTRE OTROS; D Y E SON INDEPENDIENTEMENTE UN ENLACE O -CH2-; F ES ARILO O HETEROARILO; G ES (g.1), ENTRE OTROS; R1 ES H, C1-6-ALQUILO, HETEROCICLIL-CO- OPCIONALMENTE SUSTITUIDO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: TER-BUTILESTER DEL ACIDO 4-[N�-(3,5-DIAMINO-6-CLORO-PIRAZIN-2-CARBONIL)-GUANIDINOMETIL]-4-FENETIL-PIPERIDIN-1-CARBOXILICO; N-(3,5-DIAMINO-6-CLORO-PIRAZIN-2-CARBONIL)-N�-(4-FENETIL-PIPERIDIN-4-ILMETIL-GUANIDINA; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN UN EFECTO INHIBIDOR EN LOS CANALES DE SODIO EPITELIALES, SIENDO UTILES PARA EL TRATAMIENTO DE BRONQUITIS CRONICA, ASMA, FIBROSIS QUISTICA, EDEMA PULMONAR, SINUSITIS CRONICA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11187553 | 2011-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20141607A1 true PE20141607A1 (es) | 2014-11-23 |
Family
ID=47073464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2014000641A PE20141607A1 (es) | 2011-11-02 | 2012-10-29 | Compuestos heterociclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparacion |
Country Status (34)
Country | Link |
---|---|
US (4) | US8759349B2 (es) |
EP (1) | EP2773633B1 (es) |
JP (1) | JP6091513B2 (es) |
KR (1) | KR102006612B1 (es) |
CN (2) | CN106279110B (es) |
AP (1) | AP2014007670A0 (es) |
AU (1) | AU2012331274B2 (es) |
BR (1) | BR112014010583A2 (es) |
CA (1) | CA2854217C (es) |
CL (1) | CL2014001047A1 (es) |
CO (1) | CO6940429A2 (es) |
CY (1) | CY1120974T1 (es) |
DK (1) | DK2773633T3 (es) |
EA (1) | EA025158B9 (es) |
EC (1) | ECSP14001929A (es) |
ES (1) | ES2645744T3 (es) |
GE (1) | GEP20186880B (es) |
HK (1) | HK1196819A1 (es) |
HR (1) | HRP20171614T1 (es) |
HU (1) | HUE034929T2 (es) |
IL (1) | IL232035A (es) |
LT (1) | LT2773633T (es) |
ME (1) | ME02905B (es) |
MX (1) | MX348522B (es) |
NO (1) | NO2773633T3 (es) |
PE (1) | PE20141607A1 (es) |
PL (1) | PL2773633T3 (es) |
PT (1) | PT2773633T (es) |
RS (1) | RS56498B1 (es) |
SG (1) | SG11201401907TA (es) |
SI (1) | SI2773633T1 (es) |
TN (1) | TN2014000180A1 (es) |
UA (1) | UA115868C2 (es) |
WO (1) | WO2013064450A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE049976T2 (hu) | 2005-12-28 | 2020-11-30 | Vertex Pharma | N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói |
ME02905B (me) * | 2011-11-02 | 2018-10-20 | Boehringer Ingelheim Int | Heterociklična jedinjenja, medikamenti koji sadrže navedena jedinjenja, njihova primjena i postupak za njihovo dobijanje |
KR20160054460A (ko) | 2013-07-02 | 2016-05-16 | 더 캘리포니아 인스티튜트 포 바이오메디칼 리써치 | 낭성 섬유증의 치료를 위한 화합물 |
WO2015003958A1 (en) * | 2013-07-08 | 2015-01-15 | Boehringer Ingelheim International Gmbh | Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways |
KR20170063954A (ko) | 2014-10-07 | 2017-06-08 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정 |
MX2017005044A (es) | 2014-10-24 | 2017-07-04 | Ono Pharmaceutical Co | Activador de canales de kcnq2-5. |
WO2016112120A1 (en) * | 2015-01-07 | 2016-07-14 | The California Institute For Biomedical Research | Compounds for treatment of cystic fibrosis |
GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
WO2022053651A2 (en) | 2020-09-10 | 2022-03-17 | Precirix N.V. | Antibody fragment against fap |
CN112107580A (zh) * | 2020-09-29 | 2020-12-22 | 北京鑫开元医药科技有限公司 | 一种脾酪氨酸激酶抑制剂的制剂组合物及其制备方法 |
WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
WO2023213801A1 (en) | 2022-05-02 | 2023-11-09 | Precirix N.V. | Pre-targeting |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6812003A (es) | 1967-09-07 | 1969-03-11 | ||
US3953476A (en) | 1971-12-27 | 1976-04-27 | Merck & Co., Inc. | 3-Amino-5-sulfonylbenzoic acids |
MXPA02000684A (es) | 1999-07-19 | 2003-07-21 | Univ North Carolina | Conjugados de bloqueadores del canal de sodio y metodos de uso de los mismos. |
WO2001052902A1 (en) | 2000-01-24 | 2001-07-26 | Isis Pharmaceuticals, Inc. | Antisense modulation of inducible nitric oxide synthase expression |
AU2005277443A1 (en) | 2004-08-18 | 2006-03-02 | Johnson, Michael R | Aliphatic amide and ester pyrazinoylguanidine sodium channel blockers |
GB0526244D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
KR101335884B1 (ko) * | 2006-07-24 | 2013-12-12 | 인터내셔날 스템 셀 코포레이션 | 망막 줄기 세포로부터 유래한 합성 각막 |
ES2361595T3 (es) * | 2007-05-07 | 2011-06-20 | Novartis Ag | Compuestos orgánicos. |
CN101939054B (zh) | 2007-12-10 | 2014-10-29 | 诺华股份有限公司 | 有机化合物 |
CA2723938A1 (en) * | 2008-05-13 | 2009-11-19 | Novartis Ag | 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
KR20110040818A (ko) | 2008-06-10 | 2011-04-20 | 노파르티스 아게 | 상피 나트륨 채널 차단제로서의 피라진 유도체 |
US9050339B2 (en) | 2010-09-17 | 2015-06-09 | Novartis Ag | Pyrazine derivatives as ENaC blockers |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
DK2723176T3 (en) | 2011-06-27 | 2017-07-31 | Parion Sciences Inc | CHEMICAL AND METABOLIC STABLE DIPEPTIDE WITH POTENT SODIUM CHANNEL BLOCK ACTIVITY |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
CN104024231A (zh) | 2011-11-02 | 2014-09-03 | 勃林格殷格翰国际有限公司 | 制备酰基胍和酰基硫脲化合物的新方法 |
ME02905B (me) | 2011-11-02 | 2018-10-20 | Boehringer Ingelheim Int | Heterociklična jedinjenja, medikamenti koji sadrže navedena jedinjenja, njihova primjena i postupak za njihovo dobijanje |
-
2012
- 2012-10-29 ME MEP-2017-247A patent/ME02905B/me unknown
- 2012-10-29 DK DK12777930.4T patent/DK2773633T3/da active
- 2012-10-29 MX MX2014005166A patent/MX348522B/es active IP Right Grant
- 2012-10-29 EP EP12777930.4A patent/EP2773633B1/en active Active
- 2012-10-29 WO PCT/EP2012/071352 patent/WO2013064450A1/en active Application Filing
- 2012-10-29 RS RS20171069A patent/RS56498B1/sr unknown
- 2012-10-29 PT PT127779304T patent/PT2773633T/pt unknown
- 2012-10-29 ES ES12777930.4T patent/ES2645744T3/es active Active
- 2012-10-29 US US13/662,791 patent/US8759349B2/en active Active
- 2012-10-29 PL PL12777930T patent/PL2773633T3/pl unknown
- 2012-10-29 BR BR112014010583A patent/BR112014010583A2/pt active Search and Examination
- 2012-10-29 HU HUE12777930A patent/HUE034929T2/en unknown
- 2012-10-29 GE GEAP201213485A patent/GEP20186880B/en unknown
- 2012-10-29 AU AU2012331274A patent/AU2012331274B2/en not_active Ceased
- 2012-10-29 NO NO12777930A patent/NO2773633T3/no unknown
- 2012-10-29 AP AP2014007670A patent/AP2014007670A0/xx unknown
- 2012-10-29 KR KR1020147012186A patent/KR102006612B1/ko active IP Right Grant
- 2012-10-29 JP JP2014539297A patent/JP6091513B2/ja active Active
- 2012-10-29 CN CN201610685839.2A patent/CN106279110B/zh active Active
- 2012-10-29 EA EA201400521A patent/EA025158B9/ru not_active IP Right Cessation
- 2012-10-29 PE PE2014000641A patent/PE20141607A1/es active IP Right Grant
- 2012-10-29 CA CA2854217A patent/CA2854217C/en not_active Expired - Fee Related
- 2012-10-29 SG SG11201401907TA patent/SG11201401907TA/en unknown
- 2012-10-29 CN CN201280065806.8A patent/CN104024244B/zh active Active
- 2012-10-29 UA UAA201405764A patent/UA115868C2/uk unknown
- 2012-10-29 SI SI201231100T patent/SI2773633T1/sl unknown
- 2012-10-29 LT LTEP12777930.4T patent/LT2773633T/lt unknown
-
2014
- 2014-04-09 IL IL232035A patent/IL232035A/en not_active IP Right Cessation
- 2014-04-24 CL CL2014001047A patent/CL2014001047A1/es unknown
- 2014-04-28 US US14/263,344 patent/US20140228374A1/en not_active Abandoned
- 2014-04-28 TN TNP2014000180A patent/TN2014000180A1/en unknown
- 2014-04-30 CO CO14092699A patent/CO6940429A2/es unknown
- 2014-05-26 EC ECIEPI20141929A patent/ECSP14001929A/es unknown
- 2014-10-15 HK HK14110269.7A patent/HK1196819A1/zh not_active IP Right Cessation
-
2015
- 2015-08-05 US US14/818,478 patent/US9920035B2/en active Active
-
2017
- 2017-10-24 HR HRP20171614TT patent/HRP20171614T1/hr unknown
- 2017-10-30 CY CY171101128T patent/CY1120974T1/el unknown
- 2017-12-13 US US15/840,309 patent/US20180194747A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20141607A1 (es) | Compuestos heterociclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparacion | |
EA201492281A1 (ru) | Соединения n-арилтриазола в качестве антагонистов рецепторов лизофосфатидной кислоты (lpar) | |
CO7131358A2 (es) | Compuestos de n-alquiltriazol como antagonistas de lpar | |
UY35288A (es) | Piridonamidas como moduladores de canales de sodio | |
DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
UY35300A (es) | Formulación de combinación de dos compuestos antivirales | |
NI201400031A (es) | Derivados de ( 4 - fenilimidazol - 2 - il ) etilamina útiles como moduladores de canal de sodio | |
UY32156A (es) | Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones. | |
BR112014009087A2 (pt) | formulações de etanercept estabilizadas com xilitol | |
CO6690768A2 (es) | Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7 | |
EA201891179A1 (ru) | N-замещенные индольные производные в качестве модуляторов pge2 рецепторов | |
PE20150224A1 (es) | Inhibidores del nampt | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
UY35275A (es) | Derivados de aminopirazina | |
EA201291217A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ | |
CU20150084A7 (es) | Derivados del ácido 4-((1,1) bisfenil -4-il)-3-(3-fosfonopropanamido)butanoico,activo como inhibidores de nep(endopeptidasa neutral) | |
EA201492283A1 (ru) | Замещенные соединения пиразола в качестве антагонистов рецепторов лизофосфатидной кислоты (lpar) | |
EA201890331A1 (ru) | Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена | |
EA201992679A1 (ru) | N-замещенные индольные производные | |
UY35535A (es) | ?Derivados de fenil sulfonamidas?. | |
EA201490152A1 (ru) | Антагонисты trpm8 и их применение при лечении | |
UY37837A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
EA201400822A1 (ru) | Производные гетероциклических амидов в качестве антагонистов p2xрецептора | |
EA201591684A1 (ru) | Кристаллические формы ингибиторов тирозинкиназы и их солей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |